About Dr. Hsu


John Hsu, MD, MBA, MSCE
Director of Clinical Economics and Policy Analysis Program, Health Policy Research Center
Associate Professor of Medicine, Harvard Medical School

John Hsu, MD, MBA, is the director of the Program for Clinical Economics and Policy Analysis within the Mongan Institute for Health Policy, which he joined in January 2010. He studies innovations in health care financing and delivery, and their effects on medical quality and efficiency. With a background in internal medicine, health services research and clinical epidemiology, and health care finance and management, Dr. Hsu brings clinical, population, and business perspectives to these studies. In his work, he primarily uses large automated and electronic health record data sets, often exploiting natural experiments from both clinical and behavioral economics perspectives. Dr. Hsu’s current work focuses on the interplay between benefit design and delivery system integration. He has collaborated closely with policy-makers and organizational decision-makers to help implement changes based on his research findings.

In 1999, after completing his medical and post-graduate training at the University of Pennsylvania, Dr. Hsu took a position at Kaiser Permanente in Oakland, CA, where most recently he served as director of the Center for Health Policy Studies in the Division of Research, Kaiser Permanente Medical Care Program. Since 2001, he has been continually funded by multiple R01 grants (including from the Agency for Healthcare Research and Quality [AHRQ], the National Institute on Aging, and National Institute of General Medical Sciences), and grants supported by the Centers for Disease Control and Prevention, The Commonwealth Fund, and the Medicare Payment Advisory Commission (MedPAC), among other sources. His AHRQ grant R01 HS013902, “Prescription Drug Cost-sharing: Effects on Affordability and Patient Safety,” was the best scored project at AHRQ in 2003. One article from this drug cost-sharing study received Article of the- ear awards from both Academy Health and the International Society of Pharmacoeconomics and Outcomes Research in 2007. Dr. Hsu has given numerous invited research and other presentations at national and international meetings, and to public and private health care stakeholders.

Current Projects

National Institutes of Health
Alzheimer’s Disease and Related Dementia Care within the Medicare Program
Goal:  Use novel information combined with modern approaches for identifying who has dementia then examine care for these patients throughout the national Medicare program
Role:  Principal Investigator

National Institutes of Health
Medicare in a Restructured Delivery System
Goal: to examine the role of private Medicare Advantage plans after the ACA payment changes
Role:  Co-Investigator

National Institutes of Health
Long-Term Impact of Fertility (LIFT) Study
Goal: To examine the long-term impact on child outcomes of modern fertility treatments including assisted reproductive technology (ART) using data from Denmark, the Netherlands, Sweden and the United States
Role: Principal Investigator

Laura and John Arnold Foundation
HealthCare Markets and Regulation Lab (State Laboratory Project)
Goal: To examine market stability, risk, and sustainability within the state Medicaid and individual insurance markets.
Role: Co-Investigator  

Dr. Hsu on PubMed

BA, Johns Hopkins University
MSCE, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
MBA, University of Pennsylvania
MD, University of Pennsylvania School of Medicine